Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
about
Identifying microRNA/mRNA dysregulations in ovarian cancerSubcellular localization of APMCF1 and its biological significance of expression pattern in normal and malignant human tissuesHigh throughput detection of M6P/IGF2R intronic hypermethylation and LOH in ovarian cancerTargeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer TreatmentClinicians' expectations for gene-driven cancer therapyProspective health care: the second transformation of medicineThe oncogenic role of Yin Yang 1Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancerAssessing the clinical utility of cancer genomic and proteomic data across tumor types.curatedOvarianData: clinically annotated data for the ovarian cancer transcriptomeIncorporating inter-relationships between different levels of genomic data into cancer clinical outcome predictionKnowledge boosting: a graph-based integration approach with multi-omics data and genomic knowledge for cancer clinical outcome prediction.Role of YY1 in the pathogenesis of prostate cancer and correlation with bioinformatic data sets of gene expressionStructured Matrix Completion with Applications to Genomic Data Integration.Bayesian Weibull tree models for survival analysis of clinico-genomic dataExpression profiling to predict the clinical behaviour of ovarian cancer fails independent evaluationGlobal gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroidsInactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.SlimPLS: a method for feature selection in gene expression-based disease classification.Development of a clinical decision model for thyroid nodulesImproved microarray-based decision support with graph encoded interactome dataExpression signatures of TP53 mutations in serous ovarian cancers.Imputing gene expression to maximize platform compatibility.Involvement of AF1q/MLLT11 in the progression of ovarian cancerYin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma.Bayesian ensemble methods for survival prediction in gene expression dataDifferential Angiogenic Gene Expression in TP53 Wild-Type and Mutant Ovarian Cancer Cell Lines.Molecular genetics complexity impeding research progress in breast and ovarian cancers.Integrated analysis of multiple microarray datasets identifies a reproducible survival predictor in ovarian cancer.Role of Pirh2 in mediating the regulation of p53 and c-Myc.Copy number variation analysis of matched ovarian primary tumors and peritoneal metastasisKnowledge-driven genomic interactions: an application in ovarian cancer.Calcium-dependent FAK/CREB/TNNC1 signalling mediates the effect of stromal MFAP5 on ovarian cancer metastatic potential.Abortive autophagy induces endoplasmic reticulum stress and cell death in cancer cells.A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study.Loss-of-heterozygosity on chromosome 19q in early-stage serous ovarian cancer is associated with recurrent diseaseA gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2.Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer.Somatic mutations favorable to patient survival are predominant in ovarian carcinomas
P2860
Q21199589-275E195D-80B7-47F2-A7F7-DD997375FC90Q24321945-A224B6FD-8CB8-4590-810C-4B99DAB4AE22Q25257400-22748B25-AC08-4E67-8D60-4CB64138E34DQ26769963-AFC3F11A-38CB-43A8-A889-9F0B4FA445B7Q28083844-F10FB936-1D10-4EEA-85AC-9FA34D3D9DF2Q28300742-92234EEE-A7F1-4E75-B69C-83D3BEBD5335Q28385924-2844541E-1407-4654-A455-CCBCA6DA54E8Q28732124-64F32DB5-BB06-4975-A468-60EC3640E66EQ30487077-715AA030-A057-4DCD-8E9B-92E9555C15BBQ30611147-C237E42C-AF72-4422-A116-01914A2D2F4BQ30762166-5FF1BA83-4703-4BAC-9C77-4D7956460494Q30835541-E445F304-F254-4850-BE38-395B43353866Q30838103-65B82EB0-1A7B-4032-B557-3FEC8D50CB54Q31152268-7BB6D969-9888-4E03-A184-C32509ED6A97Q31162240-5E41D058-D90F-47F4-8230-8C279BDACB1AQ33315705-433328C5-362C-449B-8276-3A8C16ADC163Q33321330-CBAF8981-B650-4EE3-B0F0-D3C92F638ABDQ33408105-C92D46FF-04EB-4521-B308-5D5177E6637BQ33489546-1B6D5BF1-109A-46AA-83CA-4D322B98DF35Q33491866-A2927174-7CA3-449B-B33F-6B14BD7CE913Q33564252-D632D02A-09E6-4CB1-B018-A31A55EF36D9Q33588196-80191C4F-2166-44E9-A001-6E9A44993AA3Q33614031-F8429A49-15F6-4E0C-97FF-B7ADC55BF08EQ33618652-74AB048E-AD57-46CB-9EA7-7F1BC3668C67Q33717981-F4A20AC0-4028-46A1-A76E-875C30F9751EQ33726112-0E693248-EF38-4820-88BB-1EAD731E5889Q33767777-F951D168-663F-451E-84A2-566CB7D2FF1EQ33781661-C91945FA-73AC-4578-8E8B-ABD133C5432BQ33858073-F6C5BEDD-C307-4278-9EFB-45AA2008A029Q33867457-42FCD4DB-91A2-468D-885C-8328ADDD288EQ34085616-D0D96D68-0777-4E86-AC6A-2EF8B0CDEB3CQ34110125-18E676CD-7B02-465E-BB8B-63DAF93E18ABQ34165543-2F836D8C-2E5E-4DD3-BE88-F8CF391EAC19Q34290146-6D23583F-AC44-4928-A17B-7A3A37EE22D5Q34321373-262B7CE5-3A4F-4878-9D1D-FC6FD15C76AAQ34348077-30F36E0D-5397-40E6-B374-AAB7D8F2A95EQ34411194-ECDE4D94-1084-46C0-BC83-EF638AB88DCBQ34433540-838C0EA3-FD59-4C13-B680-FF2063D55536Q34452297-9EA5C2E3-1023-4998-8E87-53E44DF32438Q34497796-73E76692-91BB-4BC7-B1EE-189CBF9D60CB
P2860
Patterns of gene expression that characterize long-term survival in advanced stage serous ovarian cancers.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Patterns of gene expression th ...... stage serous ovarian cancers.
@en
Patterns of gene expression th ...... stage serous ovarian cancers.
@nl
type
label
Patterns of gene expression th ...... stage serous ovarian cancers.
@en
Patterns of gene expression th ...... stage serous ovarian cancers.
@nl
prefLabel
Patterns of gene expression th ...... stage serous ovarian cancers.
@en
Patterns of gene expression th ...... stage serous ovarian cancers.
@nl
P2093
P1476
Patterns of gene expression th ...... d stage serous ovarian cancers
@en
P2093
Andrew Berchuck
Edwin S Iversen
Holly K Dressman
Jeffrey R Marks
Jennifer Pittman
Jingqin Luo
Johnathan M Lancaster
Joseph R Nevins
P304
P356
10.1158/1078-0432.CCR-04-2398
P407
P577
2005-05-01T00:00:00Z